Solence, founded in 2022 by Clara Stephenson, develops an AI-powered, personalised digital therapeutic app to support women with PCOS. Its first product is a twelve-week program of interactive lessons rooted in peer-reviewed research that delivers personalised lifestyle interventions and monthly PCOS assessment scores to map triggers and track symptoms. The company says it harnesses data insights and habit-formation science to tailor care beyond medication and to address the heterogeneity of PCOS expressions. Solence grew from Stephenson's Les Natives blog, which recorded over 135,000 visits and about 8,000 followers, demonstrating early consumer demand and engagement. A scientific committee including Professor Michel Pugeat and Dr. Nour Mimouni supports the clinical framing of the product. The startup plans to deepen product functionality and expand the team as it scales its patient-centric approach amid widespread misinformation and unaffordable PCOS care in Europe.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2025